Dysphoric Project

Nonprofit Advocacy Project | Psychedelics & Periods| Harm Reduction & Research

[Dysphoric Project @Dysphoric_]

The First Psychedelic Clinical Trial for PMDD + Updates on our Open Letter to the FDA, by @TinaWitB https://t.co/PquYzllMMZ

[Dysphoric Project @Dysphoric_]

Integrating women's health into psychedelic research is good scientific practice. It's also vital for harm reduction:

Open Letter to the FDA: https://t.co/LTdhf9C7CI

#psychedelicresearch #WomensHealth #harmreduction